An Effectiveness and Safety Study of CONCERTA* vs. Immediate Release Methylphenidate (IR MPH) in Attention Deficit Hyperactivity Disorder Children
PHASE3CompletedINTERVENTIONAL
Enrollment
147
Participants
Timeline
Start Date
Not specified
Study Completion Date
February 29, 2004
Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG
OROS*-Methylphenidate
All Listed Sponsors
lead
Janssen-Ortho Inc., Canada
INDUSTRY
NCT00304681 - An Effectiveness and Safety Study of CONCERTA* vs. Immediate Release Methylphenidate (IR MPH) in Attention Deficit Hyperactivity Disorder Children | Biotech Hunter | Biotech Hunter